Overview

Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients

Status:
Terminated

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the efficacy and safety of dalteparin vs unfractionated heparin for the prevention of VTE (Venous Thromboembolism) in hospitalized acutely ill medical patients.

Phase:

Phase 4

Details

Lead Sponsor:

Pfizer

Treatments:

Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin